Aerobic Exercise in Women With Gestational Diabetes
GDM-FIT
Efficacy of Supervised Physical Exercise in Metabolic Control of Women With Gestational Diabetes
1 other identifier
interventional
48
1 country
1
Brief Summary
A few, small randomized controlled trials have investigated the effects of exercise on blood glucose levels in women with gestational diabetes (GDM), with inconsistent results. To assess the effects of supervised exercise in women with GDM, 48 women with gestational diabetes, diagnosed between the 18th and 28th week of gestation, will be recruited, after exclusion of subjects with contraindications to exercise. These subjects will be randomly assigned to two groups: structured exercise intervention or standard care. Women in the intervention group will perform low intensity aerobic exercise three times per week at 30% HRR (heart rate reserve), under continuous heart rate monitoring. Duration of each session will progress from 26 minutes the first week to 40 minutes (increasing 2 min/week). Women in the control group will receive standard diet and physical exercise recommendations. In all women, clinical, metabolic and anthropometric features will be assessed before, during and at the end of the study. Newborn data will also be collected.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2012
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 27, 2012
CompletedFirst Submitted
Initial submission to the registry
February 3, 2017
CompletedFirst Posted
Study publicly available on registry
March 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2022
CompletedMay 6, 2021
May 1, 2021
9.8 years
February 3, 2017
May 4, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Change in fasting plasma glucose levels (mg/dL)
Before intervention and at 35-37 week of gestation
Secondary Outcomes (28)
Change in body weight (kg)
Before intervention and at 35-37 week of gestation
Change in body mass index (kg/m^2, weight in kilograms, height in meters)
Before intervention and at 35-37 week of gestation
Change in blood pressure (mmHg)
Before intervention and at 35-37 week of gestation
Change in heart rate (HR, beats per minute)
Before intervention and at 35-37 week of gestation
Dosage of insulin therapy, if required
Before intervention and at 35-37 week of gestation
- +23 more secondary outcomes
Study Arms (2)
Supervised exercise intervention
EXPERIMENTALWomen in the intervention group will perform low intensity aerobic exercise three times per week at 30% HRR (Heart Rate Reserve), under continuous heart rate monitoring. Duration of each session will progress from 26 minutes the first week to 40 minutes (by increasing 2 min/week).
Current standard of care
NO INTERVENTIONWomen in the control group will receive standard physical exercise recommendations.
Interventions
Eligibility Criteria
You may qualify if:
- Singleton pregnancy,
- Gestational diabetes diagnosis between 18th and 28th week of gestation,
- Caucasian.
You may not qualify if:
- Hemodynamically significant heart disease,
- Restricted lung disease,
- Incompetent cervix/cerclage,
- Persistent second or third trimester bleeding,
- Placenta previa,
- Threatened preterm labor,
- Ruptured membranes,
- Preeclampsia,
- Hypertension,
- Severe anemia,
- Cardiac arrhythmias,
- History of epilepsy,
- Chronic bronchitis,
- Orthopedic limitations,
- Overt hyperthyroidism/ hypothyroidism,
- +2 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Endocrinology, Diabetes and Metabolism Section, Department of Medicine, University of Verona and Azienda Ospedaliera Universitaria Integrata of Verona
Verona, 37126, Italy
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Paolo Moghetti, MD, PhD
University of Verona and Azienda Ospedaliera Universitaria Integrata of Verona
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Prof.
Study Record Dates
First Submitted
February 3, 2017
First Posted
March 1, 2017
Study Start
September 27, 2012
Primary Completion
June 30, 2022
Study Completion
December 30, 2022
Last Updated
May 6, 2021
Record last verified: 2021-05
Data Sharing
- IPD Sharing
- Will not share